Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus
about
Dysregulation of antiviral helicase pathways in systemic lupus erythematosusNucleic Acid sensors and type I interferon production in systemic lupus erythematosusType I interferon blockade in systemic lupus erythematosus: where do we stand?Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLEAdvances in lupus geneticsFamilial aggregation of autoimmune disease in juvenile dermatomyositisIRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosusBrief Report: IRF5 systemic lupus erythematosus risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in mothers of children with neonatal lupusAdmixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody productionImmunogenicity and Lupus-Like Autoantibody Production Can Be Linked to Each Other along With Type I Interferon Production in Patients with Rheumatoid Arthritis Treated With Infliximab: A Retrospective Study of a Single Center CohortAbnormalities of frontal-parietal resting-state functional connectivity are related to disease activity in patients with systemic lupus erythematosus.Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus.An essential role of caspase 1 in the induction of murine lupus and its associated vascular damageTwo major autoantibody clusters in systemic lupus erythematosusActivation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes.Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients.Association of functional polymorphisms in interferon regulatory factor 2 (IRF2) with susceptibility to systemic lupus erythematosus: a case-control association study.Sex Differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE)Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus.Sex differences in monocyte activation in systemic lupus erythematosus (SLE).Interferon regulatory factors in human lupus pathogenesisGenetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.Interferon regulatory factors: critical mediators of human lupus.Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosusInflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus.B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels.Interferon alpha as a primary pathogenic factor in human lupusWidely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populationsGenome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus Erythematosus.Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus.The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes.Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients.Role of cytokines in systemic lupus erythematosus: recent progress from GWAS and sequencing.Myeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onsetGenetic ancestry, serum interferon-α activity, and autoantibodies in systemic lupus erythematosusLarge-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosusGene-expression-guided selection of candidate loci and molecular phenotype analyses enhance genetic discovery in systemic lupus erythematosus.Enhanced rho-associated protein kinase activation in patients with systemic lupus erythematosus.Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity.Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients.
P2860
Q21129494-B521FA96-48A0-415B-8385-2D5A97B3E0B4Q21131202-D011891C-13D9-4CDA-BF7F-73F3041496A9Q26865441-339B31CD-AAA8-43D6-9383-806DC37FCD89Q27003201-A545358B-BB69-4806-B135-B4BF2B3E57F3Q28088718-F4B4EA92-CFF1-4911-B667-1DE49E70E156Q28235854-B6DEEF61-8661-415C-9052-0D44509EB1B4Q28253129-75A2BAF9-C09B-495A-A6DD-B6B2995DE504Q28268287-237F401D-CB27-4843-A5AD-37C3BFFFC67EQ28486228-34F2B03A-5B61-45EC-A05E-A2323717BD3FQ28554222-59D87BE5-DE11-4BCC-8DBB-AE28A4DBBCC9Q33163321-CFE26D2F-A31D-4F47-8B89-0DF4604DF2BAQ33398517-6A35EE66-AEF1-4298-9AFE-E0B6577C6E6BQ34055844-C20730E1-C26A-48E4-AAB7-AE0A46E1F1BFQ34171558-C0376C09-51B0-4A84-AA92-6D81A07B523BQ34240254-BAF63CDC-D449-43CA-B47E-442F8906462EQ34273836-BF6475ED-ECCA-40DB-B258-72BD87190993Q34294364-855083C0-2B4D-4E90-BB08-E35FF6867A6FQ34323715-368BE1D6-33C0-4F39-B40E-C24FAECBD0DCQ34583337-6E2873A8-0782-43A3-87E7-D61015432BBAQ34653871-BAB76245-04D9-4987-9588-4388B74C6060Q34988497-6FEC66FB-A9B5-42BE-AFF2-7D54CDCC432EQ35008001-C24D28A8-6F3E-49E9-8FA5-301B6D741837Q35014051-AE41F875-46FB-4BC3-AE4E-B43FD3257DC3Q35146576-3C312185-3678-4E08-AD60-F721D116C0B0Q35566819-B293723C-0A91-4D90-A220-F2380AC1B001Q35602526-85B67FFF-883C-4EA4-ADC0-99371212F47BQ35603587-F7F8407F-5443-46D4-A27F-C2E82B88F521Q35688808-EC51CF09-C6EB-4DD6-A003-EA7FC05035D6Q35698898-F417F95C-4F3F-4D00-8D10-ABBB3D9C5E8DQ35743904-06D7474F-CD87-45E9-A5D4-2BBA4650EF2AQ35832505-3FC99516-E8E6-4A9B-A48E-4136D207B0DDQ35832527-12E1FBBE-3EDB-4C91-A841-D1060EDFA123Q35986928-0844AD31-340C-47BA-B5E4-F3F3ACBC93B8Q36054583-1AA8BB6B-3BC4-4BCC-A8C5-40DD4E9E3BE7Q36054951-1B15586A-141E-4495-A7EF-9C21CB9215DAQ36095071-3E7B365B-45BE-4777-9322-6A96939611B7Q36228760-E9262784-9F8E-49B2-AC4F-81FA55989E37Q36901827-ECB74207-EDEF-4C32-938C-A6ED35C605D7Q36907736-C4A35FCA-B0CC-4414-A078-432B8E6AC007Q37208233-49C2FD12-375F-45AA-BC1F-3CC3374786D8
P2860
Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Network analysis of associatio ...... n systemic lupus erythematosus
@ast
Network analysis of associatio ...... n systemic lupus erythematosus
@en
Network analysis of associatio ...... n systemic lupus erythematosus
@nl
type
label
Network analysis of associatio ...... n systemic lupus erythematosus
@ast
Network analysis of associatio ...... n systemic lupus erythematosus
@en
Network analysis of associatio ...... n systemic lupus erythematosus
@nl
prefLabel
Network analysis of associatio ...... n systemic lupus erythematosus
@ast
Network analysis of associatio ...... n systemic lupus erythematosus
@en
Network analysis of associatio ...... n systemic lupus erythematosus
@nl
P2093
P2860
P50
P3181
P356
P1476
Network analysis of associatio ...... n systemic lupus erythematosus
@en
P2093
Beverly S Franek
Corinna E Weckerle
Marissa Kumabe
Meenakshi Jolly
Rachel A Mikolaitis
Stephanie L Green
Tammy O Utset
P2860
P304
P3181
P356
10.1002/ART.30187
P407
P577
2011-04-01T00:00:00Z